1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-781.
2. Clinical states in prostate cancer: toward a dynamic model of disease progression
3. Natural History of Biochemical Recurrence after Radical Prostatectomy: Risk Assessment for Secondary Therapy
4. Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, Armitage GR, Wilson JJ, Venner PM, Coppin CM. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol 1996;14:1756-1764.
5. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer